144 related articles for article (PubMed ID: 23400706)
1. Predictive value of conjointly examined IL-1ra, TNF-R I, TNF-R II, and RANTES in patients with primary glomerulonephritis.
Zwiech R
J Korean Med Sci; 2013 Feb; 28(2):261-7. PubMed ID: 23400706
[TBL] [Abstract][Full Text] [Related]
2. [Prognostic values of serum concentration and urinary excretion of interleukin-1 receptor antagonist and tumor necrosis factor receptors type I and II in patients with IGA nephropathy].
Zwiech R; Kacprzyk F; Szuflet A; Nowicki M
Pol Arch Med Wewn; 2005 Apr; 113(4):326-33. PubMed ID: 16209246
[TBL] [Abstract][Full Text] [Related]
3. [Serum levels and urinary excretion of soluble receptors for tumor necrosis factor (sTNF R) in patients with primary glomerulonephritis].
Kacprzyk F
Pol Arch Med Wewn; 2002 Mar; 107(3):215-21. PubMed ID: 12107979
[TBL] [Abstract][Full Text] [Related]
4. Macrophage migration inhibitory factor urinary excretion revisited – MIF a potent predictor of the immunosuppressive treatment outcomes in patients with proliferative primary glomerulonephritis.
Zwiech R
BMC Immunol; 2015 Aug; 16():47. PubMed ID: 26272322
[TBL] [Abstract][Full Text] [Related]
5. S-Fas urinary excretion helps to predict the immunosuppressive treatment outcomes in patients with proliferative primary glomerulonephritis.
Zwiech R
J Korean Med Sci; 2013 Oct; 28(10):1474-81. PubMed ID: 24133352
[TBL] [Abstract][Full Text] [Related]
6. Effects of soluble TNF receptor II (sTNF-RII), IL-1 receptor antagonist (IL-1ra), tumor load and hypermetabolism on malnutrition in children with acute leukemia.
Schmid I; Schmitt M; Streiter M; Meilbeck R; Haas RJ; Stachel DK
Eur J Med Res; 2005 Nov; 10(11):457-61. PubMed ID: 16354598
[TBL] [Abstract][Full Text] [Related]
7. Imbalances between tumor necrosis factor-alpha and its soluble receptor forms, and interleukin-1beta and interleukin-1 receptor antagonist in BAL fluid of cavitary pulmonary tuberculosis.
Tsao TC; Hong Jh; Li LF; Hsieh MJ; Liao SK; Chang KS
Chest; 2000 Jan; 117(1):103-9. PubMed ID: 10631206
[TBL] [Abstract][Full Text] [Related]
8. Soluble TNF-alpha receptor and IL-1 receptor antagonist elevation in BAL in active pulmonary TB.
Tsao TC; Li L; Hsieh M; Liao S; Chang KS
Eur Respir J; 1999 Sep; 14(3):490-5. PubMed ID: 10543265
[TBL] [Abstract][Full Text] [Related]
9. Induction of serum soluble tumor necrosis factor receptor II (sTNF-RII) and interleukin-1 receptor antagonist (IL-1ra) by interferon beta-1b in patients with progressive multiple sclerosis.
Comabella M; Julià E; Tintoré M; Brieva L; Téllez N; Río J; López C; Rovira A; Montalban X
J Neurol; 2008 Aug; 255(8):1136-41. PubMed ID: 18484235
[TBL] [Abstract][Full Text] [Related]
10. [Serum concentration and urinary excretion of soluble receptors for tumor necrosis factor in patients with primary glomerulonephritis].
Kacprzyk F
Pol Merkur Lekarski; 2003 Oct; 15(88):383-6; discussion 386-7. PubMed ID: 14974372
[TBL] [Abstract][Full Text] [Related]
11. Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome.
van Bommel EF; Hesse CJ; Jutte NH; Zietse R; Bruining HA; Weimar W
Ren Fail; 1997 May; 19(3):443-54. PubMed ID: 9154661
[TBL] [Abstract][Full Text] [Related]
12. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
[TBL] [Abstract][Full Text] [Related]
13. Elevation of serum soluble tumour necrosis factor (TNF) receptor and IL-1 receptor antagonist levels in bronchial asthma.
Yoshida S; Hashimoto S; Nakayama T; Kobayashi T; Koizumi A; Horie T
Clin Exp Immunol; 1996 Oct; 106(1):73-8. PubMed ID: 8870701
[TBL] [Abstract][Full Text] [Related]
14. Soluble cytokine receptors sTNFR I and sTNFR II, receptor antagonist IL-1ra, and anti-inflammatory cytokines IL-10 and IL-13 in the pathogenesis of systemic inflammatory response syndrome in the course of burns in children.
Sikora JP; Kuzański W; Andrzejewska E
Med Sci Monit; 2009 Jan; 15(1):CR26-31. PubMed ID: 19114968
[TBL] [Abstract][Full Text] [Related]
15. Abnormal gene expression of proinflammatory cytokines and their membrane-bound receptors in the lymphocytes of depressed patients.
Rizavi HS; Ren X; Zhang H; Bhaumik R; Pandey GN
Psychiatry Res; 2016 Jun; 240():314-320. PubMed ID: 27138824
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretion of soluble tumour necrosis factor receptor 1 as a marker of increased risk of progressive kidney function deterioration in patients with primary chronic glomerulonephritis.
Idasiak-Piechocka I; Oko A; Pawliczak E; Kaczmarek E; Czekalski S
Nephrol Dial Transplant; 2010 Dec; 25(12):3948-56. PubMed ID: 20525973
[TBL] [Abstract][Full Text] [Related]
17. Increased serum leptin concentrations correlate with soluble tumour necrosis factor receptor levels in patients with cirrhosis.
Lin SY; Wang YY; Sheu WH
Clin Endocrinol (Oxf); 2002 Dec; 57(6):805-11. PubMed ID: 12460331
[TBL] [Abstract][Full Text] [Related]
18. [Serum level and urinary excretion of RANTES in patients with primary glomerulonephritis].
Kacprzyk F
Pol Arch Med Wewn; 2002 Sep; 108(3):837-42. PubMed ID: 12600179
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis.
Tang WW; Feng L; Vannice JL; Wilson CB
J Clin Invest; 1994 Jan; 93(1):273-9. PubMed ID: 7904269
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-1 receptor antagonist, soluble tumor necrosis factor-alpha receptor type I and II, and soluble E-selectin serum levels in multiple sclerosis patients receiving weekly intramuscular injections of interferon-beta1a.
Perini P; Tiberio M; Sivieri S; Facchinetti A; Biasi G; Gallo P
Eur Cytokine Netw; 2000 Mar; 11(1):81-6. PubMed ID: 10705303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
